Glossary
The Glossary contains a list of terminology that frequently appears in our reports and presentations.
| Term | Definition |
|---|---|
| 510(k) | Premarket Notification to the FDA, under Section 510(k) of the Food, Drug and Cosmetic Act, of intent to market a medical device in the USA |
| AGM | Annual General Meeting |
| ANZ | Australia and New Zealand |
| APES | Standards issued by the Accounting Professional & Ethical Standards Board (APESB) |
| ASUM | Australian Society for Ultrasound in Medicine |
| ASX | Australian Securities Exchange Limited |
| CDC | Centre for Disease Control (USA) |
| DESP | Deferred Employee Share Plan |
| EESP | Exempt Employee Share Plan |
| EPS | Earnings Per Share |
| ESOP | Employee Share Option Plan |
| FDA | Food and Drug Administration – USA |
| Financial Year | Year to 30 June |
| Fiscal Year | Year to 30 June |
| FY | Financial year, eg. FY2011 is the financial year ending 30 June 2011 |
| Group | ImpediMed Limited and its wholly owned subsidiary companies |
| GSOP | General Share Option Plan |
| GST | Goods and Services Tax |
| IASB | International Accounting Standards Board |
| IFRS | International Financial Reporting Standards |
| IP | Intellectual Property |
| ISO 13485 | Quality Management System for Medical Devices – Requirements for Regulatory Purposes |
| KMP | Key Management Personnel (excludes non-Executive Directors) |
| LTI | Long Term Incentive |
| OEM | Original Equipment Manufacturer |
| PCT | Patent Co-operation Treaty |
| Q1, 2, 3, or 4 | 3-monthly periods beginning 1 July, 1 October, 1 January and 1 April respectively |
| R&D | Research and Development |
| Reporting period | Year to 30 June |
| RoHS compliant | Restriction of Hazardous Substances |
| STI | Short Term Incentive |
| TEC | Total Employment Cost |
| TGA | Therapeutic Goods Administration – Australia |